TipRanks
InMed Pharmaceuticals (DE:MWG)
FRANKFURT:MWG
Germany Market
MWG
InMed Pharmaceuticals
RESEARCH TOOLSreports

InMed Pharmaceuticals (MWG) Income Statement

1 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q4 2026), InMed Pharmaceuticals's total revenue was C$2.06B, an increase of 115691.64% from the same quarter last year. In Q4, InMed Pharmaceuticals's net income was C$-5.08M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 3.18B$ 4.94M$ 4.60M$ 4.14M$ 1.09M
Gross Profit
$ 709.84M$ 1.71M$ 1.10M$ 1.40M$ 543.55K
Operating Expenses
$ 9.19M$ 9.62M$ 9.24M$ 9.78M$ 14.34M
Depreciation and Amortization
$ 708.36K$ 534.73K$ 604.52K$ 596.00K$ 511.79K
EBITDA
$ -9.19M$ -7.26M$ -7.06M$ -7.34M$ -18.09M
Operating Income
$ -9.90M$ -7.92M$ -8.13M$ -8.38M$ -13.79M
Other Income/Expenses
$ -1.48M$ -244.14K$ 465.98K$ 444.26K$ -4.81M
Pretax Income
$ -11.37M$ -8.16M$ -7.67M$ -7.93M$ -18.60M
Net Income
$ -12.56M$ -8.16M$ -7.68M$ -7.95M$ -18.60M
Per Share Metrics
Basic EPS
$ -3.12$ -8.36$ -20.14$ -64.92$ -16.58K
Diluted EPS
$ -3.12$ -8.36$ -20.14$ -64.92$ -16.58K
Weighted Average Shares Outstanding
 4.16M 975.99K 381.05K 122.42K 1.12K
Weighted Average Shares Outstanding (Diluted)
 4.16M 975.99K 381.05K 122.42K 1.12K

InMed Pharmaceuticals Earnings and Revenue History